ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
78.12 EUR
+0.06 (+0.08%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- ABL had positive earnings in the past year.
- ABL had a positive operating cash flow in the past year.
- In the past 5 years ABL has always been profitable.
- In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
- ABL's Return On Assets of 7.52% is amongst the best of the industry. ABL outperforms 85.25% of its industry peers.
- Looking at the Return On Equity, with a value of 12.51%, ABL belongs to the top of the industry, outperforming 80.33% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 9.14%, ABL is in the better half of the industry, outperforming 75.41% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 10.31%.
- The last Return On Invested Capital (9.14%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.14% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- ABL has a better Profit Margin (14.72%) than 88.52% of its industry peers.
- ABL's Profit Margin has improved in the last couple of years.
- With a decent Operating Margin value of 18.78%, ABL is doing good in the industry, outperforming 77.05% of the companies in the same industry.
- ABL's Operating Margin has improved in the last couple of years.
- ABL has a Gross Margin (56.66%) which is in line with its industry peers.
- ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.78% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.66% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, ABL has more shares outstanding
- ABL has less shares outstanding than it did 5 years ago.
- ABL has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.52 indicates that ABL is not in any danger for bankruptcy at the moment.
- The Altman-Z score of ABL (4.52) is better than 77.05% of its industry peers.
- The Debt to FCF ratio of ABL is 1.75, which is an excellent value as it means it would take ABL, only 1.75 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 1.75, ABL is doing good in the industry, outperforming 78.69% of the companies in the same industry.
- ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- ABL has a Debt to Equity ratio of 0.19. This is in the better half of the industry: ABL outperforms 68.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.52 |
ROIC/WACC1.09
WACC8.42%
2.3 Liquidity
- A Current Ratio of 1.58 indicates that ABL should not have too much problems paying its short term obligations.
- ABL has a Current ratio (1.58) which is comparable to the rest of the industry.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Quick ratio of 1.18. This is comparable to the rest of the industry: ABL outperforms 49.18% of its industry peers.
- ABL does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 9.00% over the past year.
- The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
- ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.59%.
- Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%
3.2 Future
- Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
- Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 7.06% on average per year.
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 17.52, which indicates a rather expensive current valuation of ABL.
- Based on the Price/Earnings ratio, ABL is valued cheaply inside the industry as 85.25% of the companies are valued more expensively.
- ABL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
- ABL is valuated correctly with a Price/Forward Earnings ratio of 14.54.
- 73.77% of the companies in the same industry are more expensive than ABL, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 22.24. ABL is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.52 | ||
| Fwd PE | 14.54 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 68.85% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.47 | ||
| EV/EBITDA | 14.17 |
4.3 Compensation for Growth
- ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.63
PEG (5Y)2.46
EPS Next 2Y10.46%
EPS Next 3Y10.33%
5. ABL.DE Dividend Analysis
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.72%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.23, ABL pays a better dividend. On top of this ABL pays more dividend than 80.33% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, ABL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.72% |
5.2 History
- On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- 63.09% of the earnings are spent on dividend by ABL. This is not a sustainable payout ratio.
- The dividend of ABL is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (4/24/2026, 7:00:00 PM)
78.12
+0.06 (+0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-16 2026-04-16/bmo
Earnings (Next)07-15 2026-07-15/bmo
Inst Owners81.92%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap135.75B
Revenue(TTM)45.13B
Net Income(TTM)6.52B
Analysts80.57
Price Target113.78 (45.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.72% |
Yearly Dividend2.03
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-0.41%
PT rev (3m)-9.11%
EPS NQ rev (1m)-0.43%
EPS NQ rev (3m)-4.74%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)0.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.52 | ||
| Fwd PE | 14.54 | ||
| P/S | 3.58 | ||
| P/FCF | 21.47 | ||
| P/OCF | 16.59 | ||
| P/B | 3.05 | ||
| P/tB | 7.03 | ||
| EV/EBITDA | 14.17 |
EPS(TTM)4.46
EY5.71%
EPS(NY)5.37
Fwd EY6.88%
FCF(TTM)3.64
FCFY4.66%
OCF(TTM)4.71
OCFY6.03%
SpS21.81
BVpS25.65
TBVpS11.11
PEG (NY)1.63
PEG (5Y)2.46
Graham Number50.7385 (-35.05%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.86% | ||
| ROIC | 9.14% | ||
| ROICexc | 10.47% | ||
| ROICexgc | 20.23% | ||
| OM | 18.78% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.66% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.28 | ||
| Cash Conversion | 83.6% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.52 |
F-Score6
WACC8.42%
ROIC/WACC1.09
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y7.06%
EBIT growth 1Y18.35%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year26.44%
EBIT Next 3Y14.4%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
How profitable is ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 7 / 10.
Is the dividend of ABBOTT LABORATORIES sustainable?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 63.09%.